Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Axel Finckh

Showing results (81-90 of 225) with videos related to

Pageof 23
Sort By:
Arthritis Care & Research|September 27, 2017
Low Hemoglobin and Radiographic Damage Progression in Early Rheumatoid Arthritis: Secondary Analysis From a Phase III TrialBurkhard Möller, Judith Everts-Graber, Stefan Florentinus, et al.
Journal of Managed Care & Specialty Pharmacy|May 7, 2015
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-AnalysisFelicity Buckley, Axel Finckh, Tom W J Huizinga, et al.
Annals of the Rheumatic Diseases|December 21, 2013
Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort studyBurkhard Möller, Menno Pruijm, Sabine Adler, et al.
Annals of the Rheumatic Diseases|March 16, 2012
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonistsAxel Finckh, Burkhard Möller, Jean Dudler, et al.
Clinical Rheumatology|September 30, 2018
Glucocorticoid injections for greater trochanteric pain syndrome: a randomised double-blind placebo-controlled (GLUTEAL) trialMichael John Nissen, Laure Brulhart, Antonio Faundez, et al.
RMD Open|October 6, 2023
Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximabTheresa Burkard, Enriqueta Vallejo-Yagüe, Kim Lauper, et al.
Annals of the Rheumatic Diseases|November 25, 2010
Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysisCarine Salliot, Axel Finckh, Wanruchada Katchamart, et al.
Inflammatory Bowel Diseases|August 6, 2015
Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort StudySaskia Ditisheim, Nicolas Fournier, Pascal Juillerat, et al.
Joint Bone Spine|May 18, 2010
Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patientsAxel Finckh, Jean Dudler, Felix Wermelinger, et al.
Microbes and Infection|November 2, 2010
Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infectionRajneesh Jha, Pragya Srivastava, Sudha Salhan, et al.
Pageof 23

Showing results (81-90 of 225) with videos related to

Sort By:
Pageof 23
Arthritis Care & Research|September 27, 2017
Low Hemoglobin and Radiographic Damage Progression in Early Rheumatoid Arthritis: Secondary Analysis From a Phase III TrialBurkhard Möller, Judith Everts-Graber, Stefan Florentinus, et al.
Journal of Managed Care & Specialty Pharmacy|May 7, 2015
Comparative Efficacy of Novel DMARDs as Monotherapy and in Combination with Methotrexate in Rheumatoid Arthritis Patients with Inadequate Response to Conventional DMARDs: A Network Meta-AnalysisFelicity Buckley, Axel Finckh, Tom W J Huizinga, et al.
Annals of the Rheumatic Diseases|December 21, 2013
Chronic NSAID use and long-term decline of renal function in a prospective rheumatoid arthritis cohort studyBurkhard Möller, Menno Pruijm, Sabine Adler, et al.
Annals of the Rheumatic Diseases|March 16, 2012
Evolution of radiographic joint damage in rituximab-treated versus TNF-treated rheumatoid arthritis cases with inadequate response to TNF antagonistsAxel Finckh, Burkhard Möller, Jean Dudler, et al.
Clinical Rheumatology|September 30, 2018
Glucocorticoid injections for greater trochanteric pain syndrome: a randomised double-blind placebo-controlled (GLUTEAL) trialMichael John Nissen, Laure Brulhart, Antonio Faundez, et al.
RMD Open|October 6, 2023
Longitudinal associations between body mass index and changes in disease activity and radiographic progression in rheumatoid arthritis patients treated with infliximabTheresa Burkard, Enriqueta Vallejo-Yagüe, Kim Lauper, et al.
Annals of the Rheumatic Diseases|November 25, 2010
Indirect comparisons of the efficacy of biological antirheumatic agents in rheumatoid arthritis in patients with an inadequate response to conventional disease-modifying antirheumatic drugs or to an anti-tumour necrosis factor agent: a meta-analysisCarine Salliot, Axel Finckh, Wanruchada Katchamart, et al.
Inflammatory Bowel Diseases|August 6, 2015
Inflammatory Articular Disease in Patients with Inflammatory Bowel Disease: Result of the Swiss IBD Cohort StudySaskia Ditisheim, Nicolas Fournier, Pascal Juillerat, et al.
Joint Bone Spine|May 18, 2010
Influence of anti-infliximab antibodies and residual infliximab concentrations on the occurrence of acquired drug resistance to infliximab in rheumatoid arthritis patientsAxel Finckh, Jean Dudler, Felix Wermelinger, et al.
Microbes and Infection|November 2, 2010
Spontaneous secretion of interleukin-17 and -22 by human cervical cells in Chlamydia trachomatis infectionRajneesh Jha, Pragya Srivastava, Sudha Salhan, et al.
Pageof 23